FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Thyrocare Technologies IPO is a book built issue of Rs 479.21 crores. The issue is entirely an offer for sale of 1.07 crore shares.
Thyrocare Technologies IPO bidding started from April 27, 2016 and ended on April 29, 2016. The shares got listed on BSE, NSE on May 9, 2016.
Thyrocare Technologies IPO price band is set at ₹420 to ₹446 per share. The minimum lot size for an application is 33 Shares. The minimum amount of investment required by retail investors is ₹14,718.
Edelweiss Financial Services Ltd, ICICI Securities Limited and Jm Financial Limited are the book running lead managers of the Thyrocare Technologies IPO, while Link Intime India Private Ltd is the registrar for the issue.
Refer to Thyrocare Technologies IPO RHP for detailed information.
IPO Date | April 27, 2016 to April 29, 2016 |
Listing Date | May 9, 2016 |
Face Value | ₹10 per share |
Price Band | ₹420 to ₹446 per share |
Lot Size | 33 Shares |
Total Issue Size | 10,744,708 shares (aggregating up to ₹479.21 Cr) |
Offer for Sale | 10,744,708 shares of ₹10 (aggregating up to ₹[.] Cr) |
Issue Type | Book Built Issue IPO |
Listing At | BSE, NSE |
Thyrocare Technologies IPO a total of 7,521,297 shares are offered. QIB: 2,148,942 (28.57%), RII: 3,760,648 (50.00%), NII: 1,611,707 (21.43%).
Anchor Investor Shares Offered | - |
QIB Shares Offered | 2,148,942 (28.57%) |
NII (HNI) Shares Offered | 1,611,707 (21.43%) |
Retail Shares Offered | 3,760,648 (50.00%) |
Total Shares Offered | 7,521,297 (100%) |
Investors can bid for a minimum of 33 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 33 | ₹14,718 |
Retail (Max) | 13 | 429 | ₹191,334 |
Lot Size Calculator |
Incorporated in 2000, Thyrocare Technologie Ltd is one of the leading pan-India diagnostic chains and conduct an array of medical diagnostic tests and profiles of tests that helps in early detection and management of disorders and diseases.
They are India's first fully automated diagnostic laboratory having its strong presence in more than 2000 cities / towns in India and internationally. As of November 30, 2015, they offered 192 tests and 54 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases.
Their laboratory process over 30,000 sample and above 1 lakh investigations every day. Their profiles of tests include 17 profiles of tests administered under their 'Aarogyam' brand. Through wholly owned subsidiary, NHL, they operate a network of molecular imaging centers in New Delhi, Navi Mumbai and Hyderabad, focused on early and effective cancer monitoring.
Particulars |
For the year/period ended (in Rs. Million) | |
31-Dec-15 | 31-Mar-15 | |
Total Revenue | 1,804.73 | 1,903.38 |
Profit After Tax (PAT) | 400.21 | 432.54 |
The object of the issue are to:
1. Achieve the benefits of listing the Equity Shares on the BSE and the NSE; and
2. Carry out the sale of up to 10,744,708 Equity Shares by the Selling Shareholders.
[Dilip Davda]
Considering the brand image and the operational methods, the company is poised for bright prospects ahead. Investment in this IPO will bring reasonable rewards in coming years. Investment may be considered for short to long term.
Read detail review...The Thyrocare Technologies IPO is subscribed 73.55 times on Apr 29, 2016 11:15:00 PM. The public issue subscribed 8.73 times in the retail category, 73.18 times in the QIB category, and 225.30 times in the NII category. Check Day by Day Subscription Details (Live Status)
Category | Subscription (times) |
---|---|
QIB | 73.18 |
NII | 225.30 |
Retail | 8.73 |
Total | 73.55 |
Listing Date | May 9, 2016 |
BSE Script Code | 539871 |
NSE Symbol | THYROCARE |
ISIN | INE594H01019 |
Final Issue Price | ₹446 per share |
Price Details |
---|
Final Issue Price |
Open |
Low |
High |
Last Trade |
BSE |
---|
₹446.00 |
₹662.00 |
₹606.00 |
₹665.40 |
₹618.10 |
NSE |
---|
₹446.00 |
₹665.00 |
₹605.80 |
₹665.00 |
₹618.80 |
Thyrocare Technologies Ltd
D/37-1, TTC Industrial Area
MIDC Turbhe,
Navi Mumbai 400 703
Phone: +(91 22) 2762 2762
Email: ramjee.d@thyrocare.com
Website: http://www.thyrocare.com
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: ttl.ipo@linkintime.co.in
Website: https://linkintime.co.in/mipo/ipoallotment.html
Thyrocare Technologies IPO is a main-board IPO of 10,744,708 equity shares of the face value of ₹10 aggregating up to ₹479.21 Crores. The issue is priced at ₹420 to ₹446 per share. The minimum order quantity is 33 Shares.
The IPO opens on April 27, 2016, and closes on April 29, 2016.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Thyrocare Technologies IPO opens on April 27, 2016 and closes on April 29, 2016.
Thyrocare Technologies IPO lot size is 33 Shares, and the minimum amount required is ₹14,718.
You can apply in Thyrocare Technologies IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Thyrocare Technologies IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Thyrocare Technologies IPO allotment status.
Useful Articles
FREE Account Opening (₹0)
FREE Intraday Trading (Eq, F&O)
|